Clinical Trial Update: Docetaxel in Treating Older Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update on docetaxel for older women with metastatic breast cancer. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED